Dr. Paul Geeleher focuses on developing and validating computational methods/approaches in cancer genomics and translational medicine. We are interested in problems such as the contribution of inherited genetic variation to disease risk and drug response in cancer, characterization of new pharmacogenomic biomarkers and drug repurposing. We are a primarily computational lab, but also have a strong wet-bench component. Our work is grounded in the objective to improve cancer patient outcome.
The Geeleher Lab is joining the Department of Computational Biology at St. Jude Children’s Research Hospital in Memphis Tennessee in February 2019. St. Jude has recently been ranked the #1 Pediatric Cancer Hospital.